$1.41
0.01[0.71%]
Last update: 7:02PM Get Real Time Here
Precigen
(NASDAQ:PGEN)Latest News for Precigen Stock (NASDAQ:PGEN)
Precigen Stock (NASDAQ: PGEN)
Categories: All
Friday, March 22, 2024
Thursday, March 21, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
- Recap: Precigen Q4 EarningsBenzinga Insights - Mar 19, 2024, 4:25PM
- Precigen Gives Business Updates, Significant Progress Made In The Development Of The PRGN-2012 Adenoverse Immunotherapy For The Treatment Of RRP; Plans To Submit A BLA Under An Accelerated Approval Pathway In 2H Of 2024Benzinga Newsdesk - Mar 19, 2024, 4:11PM
- Precigen EPS $(0.39) Vs $(0.40) YoY; Cash, Cash Equivalents, Short-Term And Long-Term Investments Totaled $62.9M As Of December 31, 2023Benzinga Newsdesk - Mar 19, 2024, 4:10PM
- Earnings Scheduled For March 19, 2024Benzinga Insights - Mar 19, 2024, 6:06AM
Monday, March 18, 2024
Monday, February 12, 2024
Tuesday, January 16, 2024
Tuesday, January 02, 2024
Friday, November 10, 2023
Tuesday, September 26, 2023
Friday, August 25, 2023
- Why Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Aug 25, 2023, 1:32PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Aug 25, 2023, 1:31PM
- Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On FridayLisa Levin - Aug 25, 2023, 10:57AM
Thursday, August 17, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Aug 10, 2023, 1:31PM
- Precigen shares are trading higher after the company announced FDA confirmation that the ongoing Phase 1/2 study of PRGN-2012 AdenoVerse Immunotherapy will serve as the pivotal study to support accelerated approva.Benzinga Newsdesk - Aug 10, 2023, 12:07PM
- Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On ThursdayLisa Levin - Aug 10, 2023, 10:39AM
- HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $6 Price TargetBenzinga Newsdesk - Aug 10, 2023, 6:42AM
Wednesday, August 09, 2023
- Precigen Says Capital Allocation Strategies Will Extend Projected Cash Runway Into 2025Benzinga Newsdesk - Aug 9, 2023, 8:02AM
- Precigen Q2 EPS $(0.08) Beats $(0.10) Estimate, Sales $1.77M Miss $2.18M EstimateBenzinga Newsdesk - Aug 9, 2023, 8:01AM
- Precigen Reports FDA Confirmation That Ongoing Phase 1/2 Study Of PRGN-2012 AdenoVerse Immunotherapy Will Serve As Pivotal Study To Support Accelerated ApprovalBenzinga Newsdesk - Aug 9, 2023, 7:06AM
- Earnings Scheduled For August 9, 2023Benzinga Insights - Aug 9, 2023, 4:54AM
Tuesday, August 08, 2023
Monday, July 24, 2023
Tuesday, July 18, 2023
Wednesday, July 12, 2023
Tuesday, June 20, 2023
Monday, June 12, 2023
Tuesday, June 06, 2023
Monday, June 05, 2023
- Precigen Announces Phase 1 Data For PRGN-3005 Autologous UltraCAR-T Cells Manufactured Overnight For Infusion Next Day To Advanced Stage Platinum Resistant Ovarian Cancer Patients At 2023 ASCO Annual MeetingBenzinga Newsdesk - Jun 5, 2023, 4:09PM
- JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price TargetBenzinga Newsdesk - Jun 5, 2023, 8:09AM
Tuesday, May 23, 2023
Thursday, May 11, 2023
Wednesday, May 10, 2023
- Precigen shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.Benzinga Newsdesk - May 10, 2023, 11:50AM
- Earnings Scheduled For May 10, 2023Benzinga Insights - May 10, 2023, 9:12AM
- Recap: Precigen Q1 EarningsBenzinga Insights - May 10, 2023, 8:08AM
- Precigen Q1 EPS $(0.10) Misses $(0.09) Estimate, Sales $1.85M Miss $2.22M EstimateBenzinga Newsdesk - May 10, 2023, 8:03AM